Early intervention with deep brain stimulation for children with ε-sarcoglycan myoclonus dystonia
Objective: To evaluate the efficacy and safety of Globus Pallidus Internus DBS (GPi-DBS) in early stages of disease course. Background: SGCE-related myoclonus-dystonia (SGCE-MD) is considered…GNAO1 related disorders: a clinical, genetic, and therapeutic update
Objective: To review the clinical phenotype and molecular findings of 125 cases with GNAO1-related disorders, delineating the typical phenotype and the phenotypic expansions and tracing…The Unmet needs for advanced Parkinson Disease in -Patients’ during the Covid-19 pandemic in Israel
Objective: To evaluate the socio-demographic profile and clinical needs of advanced Parkinson's disease patients who were admitted to the neurological department at TASMC during the…Feasibility of telephonic voice samples to remotely monitor people with Parkinson’s disease residing in medically underserved rural regions
Objective: To explore the feasibility of collecting voice samples using digital voicemail in People with Parkinson’s disease (PwPD). Background: For many PwPD, the increased adoption…Characteristics and validity of technologies analyzing voice features to assess symptoms – a review
Objective: Our goal was to review the current literature aiming to (i) list, (ii) compare and (iii) classify voice-based technologies that objectively measure the presence…Role of surface EMG analysis in distinguishing clonic seizures from tremors
Objective: To compare surface EMG characteristics of clonic seizures with tremors. Background: Clonic seizures can clinically mimic tremors. In cases with poor or no EEG…Deterioration in Wilson’s Disease despite treatment. Are the neuroimaging findings useful as prognostic factor?
Objective: To describe the neuroimaging findings and their importance in the prognosis during the treatment. Additionally, to describe the state of art of the treatment.…Burden of COVID-19 among patients with Parkinson’s disease and associated clinical outcomes: Evidence from a meta-analysis
Objective: To understand the burden of covid-19 among patients with Parkinson’s disease and associated clinical outcomes. Background: COVID-19 has affected millions of patients around the…The study of clonidine growth hormone study amongst definite MSA, PD, PSP, and PAF patients to assess its feasibility as a future non-invasive biomarker
Objective: To analyze the sensitivity and specificity of the clonidine growth hormone (CGH) to distinguish probable multiple system atrophy (MSA) from pure autonomic failure (PAF),…The Edmond J. Safra Fellowship in Movement Disorders: A Global Network of Parkinson’s Experts
Objective: To train more movement disorder clinician-researchers around the world to meet growing care and research needs in Parkinson’s and related disorders. Background: Care from…
- « Previous Page
- 1
- …
- 70
- 71
- 72
- 73
- 74
- …
- 153
- Next Page »